BOTHELL, Wash. , Feb. 17, 2026 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy...
BOTHELL, Wash. , Feb. 12, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy...
Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth quarter
New conference and laboratory facility to showcase the company's product portfolio and serve as a research and training hub to advance biopreservation and cell processing innovation
BOTHELL, Wash. , Nov. 17, 2025 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the...
Cell Processing revenue of $25.4 million, up 33% over Q3 2024
BOTHELL, Wash. , Oct. 23, 2025 /PRNewswire/ -- BioLife Solutions, Inc . (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy...
Northland Securities analyst Carl Byrnes maintained a Buy rating on BioLife Solutions today and set a price target of $31.00. The company’s shares closed yesterday at $26.30.Elevate Your Investing Strategy:...
Jefferies analyst reiterated a Buy rating on BioLife Solutions today and set a price target of $30.00. The company’s shares closed yesterday at $26.30.Elevate Your Investing Strategy: Take advantage...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ClearPoint Neuro (CLPT – Research Report), BioLife Solutions (BLFS – Research Report) and Viking Therapeutics...